Krebs Biochemicals & Industries Ltd.
Snapshot View

116.50 +1.85 ▲1.6%

23 September 2022, 04:01:00 PM
Volume: 539

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.krebsbiochem.com
Market Cap 246.65 Cr.
Enterprise Value(EV) 394.10 Cr. 2022-03
Financial Indicators
Earnings per share (EPS) -20.06 Trailing Twelve Months Ending 2022-06
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2022-06
Industry PE 30.97 Trailing Twelve Months Ending 2022-06
Book Value / Share -38.44 Trailing Twelve Months Ending 2022-06
Price to Book Value -2.98 Calculated using Price: 114.40
Dividend Yield 0.00 Period Ending 2021-03
No. of Shares Subscribed 2.16 Cr. 21,560,586 Shares
FaceValue 10
Company Profile
Krebs Biochemicals & Industries (KBIL) was established in the year 1991 as a Public Limited Company with the main objective of establishing commercially viable biotech processes with applications in Medicine, Agriculture Industry. The company has pioneered in the fermentation technology over the last decade.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
+1.61%
1 Week
-5.48%
1 Month
-0.98%
3 Month
+10.79%
6 Month
-23.91%
1 Year
-37.85%
2 Year
+37.87%
5 Year
+33.79%
10 Year
+507.09%
9 years 2013-06 2014-09 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03
Return on Equity (%) -97.77 -75.26 -683.34 -296.70
Return on Capital Employed (%) -14.60 -3.91 -4.33 -25.38 -27.13 -28.95 -35.41 -56.96 -44.33
Return on Assets (%) -10.72 -3.19 -6.44 -14.60 -13.46 -14.38 -14.92 -20.91 -19.36

Balance Sheet View Details >>

Particulars 10 years 2013-06 Rs. Cr. 2014-09 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03* Rs. Cr.
Shh. Funds 8 4 18 13 1 -18 -14 -25 -43 -75
Non Curr. Liab. 57 23 60 74 89 101 102 116 154 187
Curr. Liab. 71 110 29 30 32 42 55 43 48 78
Minority Int.
Equity & Liab. 136 136 107 116 122 126 142 134 159 190
Non Curr. Assets 97 98 92 107 109 109 111 115 138 154
Curr. Assets 38 39 15 9 13 17 31 19 21 35
Misc. Exp. not W/O
Total Assets 136 136 107 116 122 126 142 134 159 190

Profit Loss View Details >>

Particulars 10 years 2013-06 Rs. Cr. 2014-09 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-06 Rs. Cr. TTM
Net Sales 11 1 4 34 48 33 54 64
Other Income 6 0 0 1 0 0 0 0 1 1
Total Income 18 0 0 2 4 34 48 34 54 65
Total Expenditure -25 -4 -5 -14 -12 -41 -58 -52 -71 -97
PBIDT -7 -4 -5 -11 -8 -7 -9 -18 -17 -32
Interest -1 0 -4 -1 -3 -5 -6 -6 -6 -4
Depreciation -8 -2 -4 -4 -4 -4 -5 -5 -7
Taxation 1 0
Exceptional Items 3 0 0 -1 0
PAT -15 -4 -8 -16 -16 -18 -20 -29 -28 -43
Adjusted EPS -15 -4 -8 -12 -11 -13 -12 -16 -14 -20

Cash Flow View Details >>

Particulars 10 years 2012-03 Rs. Cr. 2013-06 Rs. Cr. 2014-09 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr.
Cash Fr. Operatn. 7 -2 49 -45 -15 -11 -6 4 -36 -15
Cash Fr. Inv. -1 6 0 -3 -4 -5 -3 -4 -10 -23
Cash Fr. Finan. -6 -4 -49 54 13 16 9 17 29 38
Net Change 0 0 0 6 -6 0 0 17 -17 1
Cash & Cash Eqvt 0 0 0 6 0 0 0 17 0 1

Shareholding Pattern View Details >>

9 Qtrs 2020-06 (%) 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%)
Promoter 70.05 70.05 70.05 70.05 72.74 72.74 72.74 72.74 72.74
Public 29.95 29.95 29.95 29.95 27.26 27.26 27.26 27.26 27.26
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Fri, 09 Sep 2022
Announcement under Regulation 30 (LODR)-Newspaper Publication
Pursuant to Regulation 30 read with Schedule III Part A Para A of SEBI Listing Regulations we have enclosed herewith copies of newspaper advertisement published in Business Standard (English) and Prajasakti (Telugu) regarding notice given to shareholders for intimating the date of Annual general meeting cut off date evoting etc.
Wed, 07 Sep 2022
30Th Annual General Meeting To Be Held On Friday The 30Th September 2022 At 11.00 A.M.
We wish to inform you that the 30th Annual General Meeting(AGM) of the Company is scheduled to be held onFriday the 30th September 2022 at 11.00 A.M.(IST) at the registered office of the Company situated at Kothapalli(V) Kasimkota (M) Ankapalli Vishakapatnam (D) Andhra Pradesh - 531031
Tue, 06 Sep 2022
Reg. 34 (1) Annual Report.
We are enclosing herewith soft copy of our Annual Report 2021-22

Technical Scans View Details >>

Fri, 23 Sep 2022
High Decrease 6 Months High Decrease 6 Months
High Decrease 1 Year High Decrease 1 Year
MFI Trending Down MFI Trending Down
CCI Oversold Zone CCI Oversold Zone
Thu, 22 Sep 2022
High Delivery Percentage High Delivery Percentage

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 220,930.76 920.80 +1.5%
Divi's Laboratories Ltd. 96,681.00 3,641.90 +1.7%
Cipla Ltd. 86,429.87 1,071.00 +0.9%
Dr. Reddy's Laboratories Ltd. 68,908.63 4,139.50 -1.0%
Apollo Hospitals Enterprise Ltd. 63,570.07 4,421.20 -4.0%
Torrent Pharmaceuticals Ltd. 51,257.56 1,514.50 -1.6%
Max Healthcare Institute Ltd. 41,385.83 426.80 -0.1%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 56.80 920.80 +1.5%
Divi's Laboratories Ltd. Consolidated 2022-06 31.13 3,641.90 +1.7%
Cipla Ltd. Consolidated 2022-06 34.73 1,071.00 +0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 23.04 4,139.50 -1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 71.96 4,421.20 -4.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 63.99 1,514.50 -1.6%
Max Healthcare Institute Ltd. Consolidated 2022-06 65.59 426.80 -0.1%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 4.41 920.80 +1.5%
Divi's Laboratories Ltd. Consolidated 2022-06 7.78 3,641.90 +1.7%
Cipla Ltd. Consolidated 2022-06 4.02 1,071.00 +0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 3.40 4,139.50 -1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 10.70 4,421.20 -4.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 8.02 1,514.50 -1.6%
Max Healthcare Institute Ltd. Consolidated 2022-06 6.43 426.80 -0.1%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.02 920.80 +1.5%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,641.90 +1.7%
Cipla Ltd. Consolidated 2022-03 0.04 1,071.00 +0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,139.50 -1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,421.20 -4.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,514.50 -1.6%
Max Healthcare Institute Ltd. Consolidated 2022-03 0.12 426.80 -0.1%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 920.80 +1.5%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,641.90 +1.7%
Cipla Ltd. Consolidated 2022-03 13.10 1,071.00 +0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,139.50 -1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,421.20 -4.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,514.50 -1.6%
Max Healthcare Institute Ltd. Consolidated 2022-03 10.19 426.80 -0.1%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 920.80 +1.5%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,641.90 +1.7%
Cipla Ltd. Consolidated 2022-03 13.10 1,071.00 +0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,139.50 -1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,421.20 -4.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,514.50 -1.6%
Max Healthcare Institute Ltd. Consolidated 2022-03 10.19 426.80 -0.1%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 920.80 +1.5%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,641.90 +1.7%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,071.00 +0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,139.50 -1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,421.20 -4.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,514.50 -1.6%
Max Healthcare Institute Ltd. Consolidated 2022-03 3,931.46 426.80 -0.1%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 920.80 +1.5%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,641.90 +1.7%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,071.00 +0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,139.50 -1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,421.20 -4.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,514.50 -1.6%
Max Healthcare Institute Ltd. Consolidated 2022-03 605.05 426.80 -0.1%

FAQ's On Krebs Biochemicals & Industries Ltd.

What is Krebs Biochem.&Inds share price?

Can I buy Krebs Biochem.&Inds shares now?

What is the Market Cap of Krebs Biochem.&Inds?

What is the 52 Week High and Low of Krebs Biochem.&Inds?

What is the trend of Krebs Biochem.&Inds share price?